Internal Medicine · Flushing, NY
NPI
1528013091
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
143-08 Roosevelt Ave, #l-2
Flushing, NY, 11354
Phone (718) 888-0502
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,644
140 services
Medicare patients, 2024
38
Average age 77
Drug cost, 2024
$7.3M
40,898 prescriptions
Company payments, 2025
$2,541
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hea-Shin Kang was code 99213 (office e&m - established), 48 times for 35 patients. In total Hea-Shin Kang billed 140 services in 11 codes, and Medicare paid $5,644.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 48 | 35 | $62.51 | $3,001 |
| 36415 Venipuncture Blood Collection | Office | 40 | 34 | $8.65 | $346 |
| 93000 Electrocardiogram | Office | 22 | 20 | $9.90 | $218 |
By year: 2022 $50K for 980 services; 2023 $42K for 831 services; 2024 $5,644 for 140 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 40 | 34 | $8.65 | $346 |
Medicare prescription drug claims, 2024
In 2024, the drug Hea-Shin Kang prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,802 prescriptions and refills. In total Hea-Shin Kang wrote 40,898 Medicare prescriptions that cost $7.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,802 | 4,171 | 432 | $9,734 |
| Vascepa Icosapent Ethyl | 2,599 | 3,151 | 331 | $1.1M |
| Amlodipine Besylate Generic | 1,997 | 2,923 | 305 | $6,727 |
| Losartan Potassium Generic | 1,640 | 2,608 | 257 | $6,111 |
| Creon Lipase/Protease/Amylase | 1,046 | 1,252 | 150 | $1.3M |
| Omeprazole Generic | 991 | 1,226 | 179 | $6,684 |
| Tamsulosin Hcl Generic | 909 | 1,269 | 142 | $3,671 |
| Metoprolol Succinate Generic | 890 | 1,295 | 134 | $4,673 |
| Diclofenac Epolamine Generic | 788 | 854 | 112 | $530K |
| Rosuvastatin Calcium Generic | 767 | 1,059 | 111 | $3,100 |
| Donepezil Hcl Generic | 759 | 1,000 | 131 | $2,851 |
| Zolpidem Tartrate Generic | 744 | 744 | 116 | $4,239 |
| Meclizine Hcl Generic | 621 | 641 | 121 | $4,818 |
| Simvastatin Generic | 597 | 934 | 93 | $2,451 |
| Raloxifene Hcl Generic | 585 | 767 | 87 | $6,940 |
Brand drugs: 10,163 claims; generic drugs: 30,102 claims; opioid claims: 83.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hea-Shin Kang $2,541 ($2,541 in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $399.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $399 |
| Abbvie Inc. ABBV | 19 | $316 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 16 | $313 |
| Axsome Therapeutics, Inc. AXSM | 8 | $260 |
| Sumitomo Pharma America, Inc. 4506.T | 10 | $228 |
| Ardelyx, Inc. ARDX | 9 | $217 |
| Amgen Inc. AMGN | 8 | $192 |
| Novo Nordisk Inc NVO | 8 | $156 |
| GlaxoSmithKline, LLC. GSK | 6 | $119 |
| Aimmune Therapeutics, Inc. | 5 | $110 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.